|Bid||0.0450 x 0|
|Ask||0.0450 x 0|
|Day's range||0.0450 - 0.0500|
|52-week range||0.0450 - 0.1400|
|Beta (5Y monthly)||-0.06|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
MISSISSAUGA, Ontario, June 30, 2022--MedX Health announces non-brokered private placement of up to $4 million of convertible loan notes.
MISSISSAUGA, Ontario, June 21, 2022--MedX Health receives final acceptance from the TSX Venture Exchange with respect to the issuance of Series II Convertible Loan Notes.
MISSISSAUGA, Ontario, June 14, 2022--MedX Health appoints CEO Naman Demaghlatrous to its Board of Directors and grows its DermSecure skin screening platform's global presence.